Shelter Pharma Secures Work Order from Verka Dairies for Supply of Veterinary Medicines Under One-Year Rate Contract

Shelter Pharma Limited has received a work order from Verka Dairies for the supply of veterinary medicines under a rate contract for a period of one year. The development follows the company's earlier successful qualification in both the technical and negotiation/financial rounds of the tender process, as intimated on 6th April, 2026. The order was formally communicated to BSE Limited on 15th May, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

About the Client

Verka Dairies is a flagship dairy brand of MILKFED Punjab and is recognised as one of the leading and most trusted dairy brands in North India. The organisation enjoys a strong market presence and consumer trust across multiple states. The receipt of this work order from such a reputed entity reflects the confidence placed by the client in Shelter Pharma's capabilities and quality standards.

Key Order Details

The following table outlines the significant terms and conditions associated with the work order, as disclosed under Regulation 30 of SEBI (LODR) Regulations, 2015:

Parameter:	Details
Awarding Entity:	Verka Dairy
Entity Type:	Domestic entity
Nature of Order:	Rate Contract for supply of Veterinary Medicines
Contract Duration:	One year from the date of rate contract, extendable for a further period of up to three months on mutual consent
Order Value:	Dependent on actual quantity/orders placed during the contract period
Pricing Basis:	F.O.D. delivered basis, inclusive of taxes, freight, insurance, packing & forwarding charges
Payment Terms:	Within 15 days from receipt and inspection of material
Delivery Timeline:	Within 30 days from the date of purchase order
Related Party Transaction:	No
Promoter/Group Interest in Client:	No

Compliance and Corporate Disclosures

The company has confirmed that neither the promoter nor the promoter group or group companies have any interest in Verka Dairies, the entity that awarded the order. Additionally, the transaction does not fall within the scope of related party transactions under applicable regulations. The disclosure was signed by Mustaqim Nisarahmed Sabugar, Managing Director of Shelter Pharma Limited, from Ahmedabad on 15th May, 2026.

Significance of the Order

The successful award of this tender underscores Shelter Pharma's commitment to maintaining high-quality products, timely execution, and reliable services. The order is expected to contribute positively to the company's revenues, profitability, and overall business growth. Management has indicated that such achievements are anticipated to further strengthen the company's market presence and order book, while creating long-term value for stakeholders.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
0.0%	+5.96%	+0.32%	-24.38%	-21.94%	-24.21%

Shelter Pharma Limited has secured repeat international purchase orders worth USD 84,450 from existing overseas customer Taha Drugs & Chemicals Co. Ltd, the company disclosed on 5th May, 2026, pursuant to Regulation 30 read with Regulation 30(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that these repeat orders reflect continued trust and satisfaction of the customer in its products and services, and signify strengthening business relations in the international market.

Order Details

The purchase orders cover two nutraceutical products to be supplied to the international entity. The following table summarises the key details of the orders as disclosed in the regulatory filing:

Parameter:	Details
Customer Name:	Taha Drugs & Chemicals Co. Ltd.
Entity Type:	International Entity
Total Order Value:	USD 84,450
Order Date:	5th May, 2026
Payment Terms:	50% advance at the time of order; balance 50% against shipping bill
Execution Timeline:	Within mutually agreed timelines as per purchase order and shipment schedule
Related Party Transaction:	No — conducted at arm's length basis
Promoter/Group Interest:	No interest in the ordering entity

Product-Wise Breakdown

The orders comprise two distinct nutraceutical product lines, as detailed below:

Product:	Quantity	Order Value
D3 Cure Capsules 3x10:	71,250 boxes	USD 48,450
Joemega Capsules 3x10:	45,000 boxes	USD 36,000
Total:		USD 84,450

About Shelter Pharma Limited

Shelter Pharma Limited is a pharmaceutical and nutraceutical company focused on research, innovation, and quality. The company operates state-of-the-art manufacturing facilities and is engaged in the development and supply of nutraceutical products aimed at promoting health and well-being. The company's Managing Director, Mustaqim Nisarahmed Sabugar (DIN: 01456841), signed the regulatory disclosure from Ahmedabad on 5th May, 2026.